Chewable Tablet Adverse Events, Manufacturing Slips Prompt Guidance
This article was originally published in The Gold Sheet
Executive Summary
Chewable tablet manufacturers are overlooking quality attributes, leading to adverse events, according to an FDA draft guidance document. The agency recommends firms establish hardness, dissolution and disintegration of products early in manufacturing.